Trial Profile
Study of venlafaxine in patients with major depressive disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2018
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 08 Nov 2018 New trial record
- 09 Oct 2018 Results presented at the 31st Annual Congress of the European College of Neuropsychopharmacology